Assunto: INFARTO DO MIOCÁRDIO (TRATAMENTO)
ABNT
PETERSEN, John L. et al. Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA, v. 292, n. 1, p. 89-96, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.accreview.2004.08.090. Acesso em: 07 nov. 2024.APA
Petersen, J. L., Mahaffey, K. W., Hasselblad, V., Antman, E. M., Cohen, M., Goodman, S. G., et al. (2004). Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA, 292( 1), 89-96. doi:10.1016/j.accreview.2004.08.090NLM
Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, Lemos JA de, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM, Marin-Neto JA. Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview [Internet]. JAMA. 2004 ; 292( 1): 89-96.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.accreview.2004.08.090Vancouver
Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, Lemos JA de, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM, Marin-Neto JA. Efficacy and bleeding complications among patients randomized to Enoxaparin or unfractionated heparin for antithrombin therapy in Non-ST-Segment elevation acute coronary syndromes: a systematic overview [Internet]. JAMA. 2004 ; 292( 1): 89-96.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.accreview.2004.08.090